Suggested strategies for the management of multiple sclerosis (MS) and
neuromyelitis optica spectrum disorder (NMOSD) during the pandemic include the
continuation of disease-modifying therapies when possible, careful assessment of the
risks and benefits of initiating or modifying immunosuppressive treatments, implementation
of telemedicine to reduce in-person visits, and adherence to public
health guidelines to minimize the risk of infection.